Literature DB >> 11206412

Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-alpha in 3T3-L1 adipocytes.

M Rosenstock1, A S Greenberg, A Rudich.   

Abstract

AIMS/HYPOTHESIS: Adipose tissue lipolysis plays a central part in total body fuel metabolism. Our study was to assess the long-term regulation of glycerol and non-esterified fatty acid (NEFA) release by insulin or TNF-alpha.
METHODS: Fully differentiated 3T3-L1 adipocytes were exposed for up to 22 h to insulin or TNF-alpha.
RESULTS: Long-term insulin treatment resulted in increased basal glycerol release, reaching sixfold at 22 h with 1 nmol/l insulin. Partial inhibition was observed by pharmacologically inhibiting phosphatidylinositol 3-kinase or the mitogen-activated kinase kinase--extracellular signal-regulated kinase cascades. This represented 50-60% of the response induced by 1 nmol/l TNF-alpha and approximately 40 % of the glycerol release maximally stimulated by isoproterenol (1 micromol/l, 30 min). The cellular mechanism seemed to be distinct from that of TNF-alpha: First, glycerol release in response to long-term insulin was progressive with time and did not display a lag-time characteristic of the effect of TNF-alpha. Second, pretreatment and co-treatment of the cells with troglitazone greatly inhibited TNF-alpha-induced glycerol release (128.5 +/- 10.2 to 35.4 +/- 2.1 nmol/mg protein per h) but not the effect of insulin, which was exaggerated. Third, hormone-sensitive lipase protein content was decreased (45 %) by TNF-alpha but not following long-term insulin. Finally, TNF-alpha was associated with NEFA release to the medium, whereas long-term insulin treatment was not. Moreover, glycerol release during isoproterenol-stimulated lipolysis was additive to the effect of long-term insulin, whereas NEFA release was inhibited by nearly 90 %. CONCLUSIONS
INTERPRETATION: Contradictory to its short-term inhibitory effect, long-term insulin stimulates glycerol release with concomitant stimulation of NEFA re-esterification.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11206412     DOI: 10.1007/s001250051580

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  11 in total

1.  Effect of iridoid glucoside on plasma lipid profile, tissue fatty acid changes, inflammatory cytokines, and GLUT4 expression in skeletal muscle of streptozotocin-induced diabetic rats.

Authors:  Ramalingam Sundaram; Palanivelu Shanthi; Panchanatham Sachdanandam
Journal:  Mol Cell Biochem       Date:  2013-04-27       Impact factor: 3.396

2.  Short-term HFD does not alter lipolytic function of adipocytes.

Authors:  Michael Sf Wiedemann; Stephan Wueest; Alexandra Grob; Flurin Item; Eugen J Schoenle; Daniel Konrad
Journal:  Adipocyte       Date:  2014-01-08       Impact factor: 4.534

3.  Monitoring cell secretions on microfluidic chips using solid-phase extraction with mass spectrometry.

Authors:  Colleen E Dugan; James P Grinias; Sebastian D Parlee; Mahmoud El-Azzouny; Charles R Evans; Robert T Kennedy
Journal:  Anal Bioanal Chem       Date:  2016-10-19       Impact factor: 4.142

4.  PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control.

Authors:  W T Festuccia; M Laplante; M Berthiaume; Y Gélinas; Y Deshaies
Journal:  Diabetologia       Date:  2006-08-14       Impact factor: 10.122

5.  Moderate alcohol consumption, glucose metabolism and lipolysis: the effect on adiponectin and tumor necrosis factor alpha.

Authors:  A Avogaro; M Sambataro; A Marangoni; A Pianta; R Vettor; C Pagano; M C Marescotti; A Tiengo; G Beltramello
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

6.  Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats.

Authors:  Sushil K Jain; Justin L Rains; Jennifer L Croad
Journal:  Free Radic Biol Med       Date:  2007-05-18       Impact factor: 7.376

7.  Silencing Jnk1 and Jnk2 accelerates basal lipolysis and promotes fatty acid re-esterification in mouse adipocytes.

Authors:  A V Rozo; R Vijayvargia; H R Weiss; H Ruan
Journal:  Diabetologia       Date:  2008-06-05       Impact factor: 10.122

8.  Glucocorticoids antagonize tumor necrosis factor-α-stimulated lipolysis and resistance to the antilipolytic effect of insulin in human adipocytes.

Authors:  Mi-Jeong Lee; Susan K Fried
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-09-04       Impact factor: 4.310

9.  Fas activates lipolysis in a Ca2+-CaMKII-dependent manner in 3T3-L1 adipocytes.

Authors:  Reto A Rapold; Stephan Wueest; Adrian Knoepfel; Eugen J Schoenle; Daniel Konrad
Journal:  J Lipid Res       Date:  2012-10-21       Impact factor: 5.922

10.  Amino acid-sensing mTOR signaling is involved in modulation of lipolysis by chronic insulin treatment in adipocytes.

Authors:  Chongben Zhang; Mee-Sup Yoon; Jie Chen
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-02-03       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.